INS and diabetes mellitus: Lebreton et al. describe the use of human amniotic epithelial cells (hAECs) in the construction of functional insulin-secreting organoids in their article “Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes” (7).